Peijia Medical participated in JenaValve’s $100m series C round while L Catterton led Planted Foods’ series B extension, lifting it to $93m.

Public markets Biocytogen Pharmaceuticals, a China-based antibody drug discovery platform developer backed by insurer China Life, has listed on the Hong Kong Stock Exchange’s Main Board. The company is set to secure about HK$471m ($60m) in net proceeds having issued nearly 21.8 million shares at HK$25.22 apiece. Funding CompanyCompany descriptionSectorCountryRoundRound size($m)Deal dateInvestorsJenaValve TechnologyDifferentiated transcatheter aortic…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.